Cargando…

Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010

BACKGROUND: Since establishment of Zimbabwe's National Antiretroviral Therapy (ART) Programme in 2004, ART provision has expanded from <5,000 to 369,431 adults by 2011. However, patient outcomes are unexplored. OBJECTIVE: To determine improvement in health status, retention and factors assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutasa-Apollo, Tsitsi, Shiraishi, Ray W., Takarinda, Kudakwashe C., Dzangare, Janet, Mugurungi, Owen, Murungu, Joseph, Abdul-Quader, Abu, Woodfill, Celia J. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906052/
https://www.ncbi.nlm.nih.gov/pubmed/24489714
http://dx.doi.org/10.1371/journal.pone.0086305
_version_ 1782301427784220672
author Mutasa-Apollo, Tsitsi
Shiraishi, Ray W.
Takarinda, Kudakwashe C.
Dzangare, Janet
Mugurungi, Owen
Murungu, Joseph
Abdul-Quader, Abu
Woodfill, Celia J. I.
author_facet Mutasa-Apollo, Tsitsi
Shiraishi, Ray W.
Takarinda, Kudakwashe C.
Dzangare, Janet
Mugurungi, Owen
Murungu, Joseph
Abdul-Quader, Abu
Woodfill, Celia J. I.
author_sort Mutasa-Apollo, Tsitsi
collection PubMed
description BACKGROUND: Since establishment of Zimbabwe's National Antiretroviral Therapy (ART) Programme in 2004, ART provision has expanded from <5,000 to 369,431 adults by 2011. However, patient outcomes are unexplored. OBJECTIVE: To determine improvement in health status, retention and factors associated with attrition among HIV-infected patients on ART. METHODS: A retrospective review of abstracted patient records of adults ≥15 years who initiated ART from 2007 to 2009 was done. Frequencies and medians were calculated for rates of retention in care and changes in key health status outcomes at 6, 12, 24 and 36 months respectively. Cox proportional hazards models were used to determine factors associated with attrition. RESULTS: Of the 3,919 patients, 64% were female, 86% were either WHO clinical stage III or IV. Rates of patient retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. After ART initiation, median weight gains at 6, 12, and 24 months were 3, 4.5, and 5.0 kgs whilst median CD4+ cell count gains at 6, 12 and 24 months were 122, 157 and 279 cells/µL respectively. Factors associated with an increased risk of attrition included male gender (AHR 1.2; 95% CI, 1.1–1.4), baseline WHO stage IV (AHR 1.7; 95% CI, 1.1–2.6), lower baseline body weight (AHR 2.0; 95% CI, 1.4–2. 8) and accessing care from higher level healthcare facilities (AHR 3.5; 95% 1.1–11.2). CONCLUSIONS: Our findings with regard to retention as well as clinical and immunological improvements following uptake of ART, are similar to what has been found in other settings. Factors influencing attrition also mirror those found in other parts of sub-Saharan Africa. These findings suggest the need to strengthen earlier diagnosis and treatment to further improve treatment outcomes. Whilst decentralisation improves ART coverage it should be coupled with strategies aimed at improving patient retention.
format Online
Article
Text
id pubmed-3906052
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39060522014-01-31 Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010 Mutasa-Apollo, Tsitsi Shiraishi, Ray W. Takarinda, Kudakwashe C. Dzangare, Janet Mugurungi, Owen Murungu, Joseph Abdul-Quader, Abu Woodfill, Celia J. I. PLoS One Research Article BACKGROUND: Since establishment of Zimbabwe's National Antiretroviral Therapy (ART) Programme in 2004, ART provision has expanded from <5,000 to 369,431 adults by 2011. However, patient outcomes are unexplored. OBJECTIVE: To determine improvement in health status, retention and factors associated with attrition among HIV-infected patients on ART. METHODS: A retrospective review of abstracted patient records of adults ≥15 years who initiated ART from 2007 to 2009 was done. Frequencies and medians were calculated for rates of retention in care and changes in key health status outcomes at 6, 12, 24 and 36 months respectively. Cox proportional hazards models were used to determine factors associated with attrition. RESULTS: Of the 3,919 patients, 64% were female, 86% were either WHO clinical stage III or IV. Rates of patient retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. After ART initiation, median weight gains at 6, 12, and 24 months were 3, 4.5, and 5.0 kgs whilst median CD4+ cell count gains at 6, 12 and 24 months were 122, 157 and 279 cells/µL respectively. Factors associated with an increased risk of attrition included male gender (AHR 1.2; 95% CI, 1.1–1.4), baseline WHO stage IV (AHR 1.7; 95% CI, 1.1–2.6), lower baseline body weight (AHR 2.0; 95% CI, 1.4–2. 8) and accessing care from higher level healthcare facilities (AHR 3.5; 95% 1.1–11.2). CONCLUSIONS: Our findings with regard to retention as well as clinical and immunological improvements following uptake of ART, are similar to what has been found in other settings. Factors influencing attrition also mirror those found in other parts of sub-Saharan Africa. These findings suggest the need to strengthen earlier diagnosis and treatment to further improve treatment outcomes. Whilst decentralisation improves ART coverage it should be coupled with strategies aimed at improving patient retention. Public Library of Science 2014-01-29 /pmc/articles/PMC3906052/ /pubmed/24489714 http://dx.doi.org/10.1371/journal.pone.0086305 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Mutasa-Apollo, Tsitsi
Shiraishi, Ray W.
Takarinda, Kudakwashe C.
Dzangare, Janet
Mugurungi, Owen
Murungu, Joseph
Abdul-Quader, Abu
Woodfill, Celia J. I.
Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
title Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
title_full Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
title_fullStr Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
title_full_unstemmed Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
title_short Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
title_sort patient retention, clinical outcomes and attrition-associated factors of hiv-infected patients enrolled in zimbabwe's national antiretroviral therapy programme, 2007–2010
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906052/
https://www.ncbi.nlm.nih.gov/pubmed/24489714
http://dx.doi.org/10.1371/journal.pone.0086305
work_keys_str_mv AT mutasaapollotsitsi patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT shiraishirayw patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT takarindakudakwashec patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT dzangarejanet patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT mugurungiowen patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT murungujoseph patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT abdulquaderabu patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010
AT woodfillceliaji patientretentionclinicaloutcomesandattritionassociatedfactorsofhivinfectedpatientsenrolledinzimbabwesnationalantiretroviraltherapyprogramme20072010